Latest news
Senhwa's CX-5461 Reaches Immuno-Oncology Milestone as its First Multicenter Combination Trial with PD-1 Inhibitor Receives TFDA Clearance - PR NewswirePR Newswire · Thu, 06 Aug 2026 09:14:00 GMTCelebrating 41 Years of Immuno-Oncology Innovation - Society for Immunotherapy of Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 18:39:42 GMTThe Future of Immuno-Oncology Clinical Trial Design – SITC - OncodailyOncodaily · Mon, 03 Aug 2026 18:20:56 GMTCGEN: AI-driven immuno-oncology pipeline advances with key AstraZeneca and Gilead partnerships - TradingViewTradingView · Mon, 03 Aug 2026 11:05:30 GMTAACR Immuno-Oncology 2027 - OncodailyOncodaily · Sun, 02 Aug 2026 22:27:24 GMTImmuno 2026: Global Virtual Congress on Immuno Oncology - OncodailyOncodaily · Tue, 28 Jul 2026 15:44:16 GMTArgenx deepens immuno expertise with $2.2B Forte Biosciences buy - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMTargenx boosts immuno expertise with buy of Forte Biosciences - The Pharma LetterThe Pharma Letter · Mon, 27 Jul 2026 07:00:00 GMT